Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Prepaid Assets (2022 - 2025)

Historic Prepaid Assets for Entrada Therapeutics (TRDA) over the last 4 years, with Q3 2025 value amounting to $10.2 million.

  • Entrada Therapeutics' Prepaid Assets fell 2364.06% to $10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year decrease of 2364.06%. This contributed to the annual value of $16.4 million for FY2024, which is 3721.07% up from last year.
  • As of Q3 2025, Entrada Therapeutics' Prepaid Assets stood at $10.2 million, which was down 2364.06% from $14.0 million recorded in Q2 2025.
  • In the past 5 years, Entrada Therapeutics' Prepaid Assets registered a high of $24.4 million during Q3 2023, and its lowest value of $8.8 million during Q1 2022.
  • Over the past 4 years, Entrada Therapeutics' median Prepaid Assets value was $13.4 million (recorded in 2024), while the average stood at $14.3 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first crashed by 4522.09% in 2024, then skyrocketed by 10157.94% in 2025.
  • Over the past 4 years, Entrada Therapeutics' Prepaid Assets (Quarter) stood at $21.2 million in 2022, then plummeted by 43.66% to $11.9 million in 2023, then skyrocketed by 37.21% to $16.4 million in 2024, then tumbled by 37.52% to $10.2 million in 2025.
  • Its Prepaid Assets was $10.2 million in Q3 2025, compared to $14.0 million in Q2 2025 and $18.6 million in Q1 2025.